219 related articles for article (PubMed ID: 27662805)
21. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
[TBL] [Abstract][Full Text] [Related]
22. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
Liu R; Liu Z; Zhang C; Zhang B
J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
[TBL] [Abstract][Full Text] [Related]
23. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin.
Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E
Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.
Savić V; Ilić T; Nikolić I; Marković B; Čalija B; Cekić N; Savić S
Int J Pharm; 2019 Oct; 569():118624. PubMed ID: 31419461
[TBL] [Abstract][Full Text] [Related]
25. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes.
Na YG; Huh HW; Kim MK; Byeon JJ; Han MG; Lee HK; Cho CW
Acta Biomater; 2020 Jan; 101():507-518. PubMed ID: 31629894
[TBL] [Abstract][Full Text] [Related]
26. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of nanostructured lipid carriers (NLC) and nanoemulsions as carriers for UV-filters: characterization, in vitro penetration and photostability studies.
Puglia C; Damiani E; Offerta A; Rizza L; Tirendi GG; Tarico MS; Curreri S; Bonina F; Perrotta RE
Eur J Pharm Sci; 2014 Jan; 51():211-7. PubMed ID: 24157543
[TBL] [Abstract][Full Text] [Related]
28. Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail.
Vitorino C; Almeida J; Gonçalves LM; Almeida AJ; Sousa JJ; Pais AA
J Control Release; 2013 May; 167(3):301-14. PubMed ID: 23454133
[TBL] [Abstract][Full Text] [Related]
29. [Preparation of isopsoralen loaded nanostructured carrier and its in vitro transdermal permeation characteristics].
Pang JY; Liu X; Shen BD; Shen CY; Lian WQ; Liu J; Hu CX; Zhong RN; Xu RC; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2473-2478. PubMed ID: 28840686
[TBL] [Abstract][Full Text] [Related]
30. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion.
Loo Ch; Basri M; Ismail R; Lau H; Tejo B; Kanthimathi M; Hassan H; Choo Y
Int J Nanomedicine; 2013; 8():13-22. PubMed ID: 23293516
[TBL] [Abstract][Full Text] [Related]
31. Hybrid Nanostructured Films for Topical Administration of Simvastatin as Coadjuvant Treatment of Melanoma.
Barone A; Mendes M; Cabral C; Mare R; Paolino D; Vitorino C
J Pharm Sci; 2019 Oct; 108(10):3396-3407. PubMed ID: 31201905
[TBL] [Abstract][Full Text] [Related]
32. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
[TBL] [Abstract][Full Text] [Related]
33. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
[TBL] [Abstract][Full Text] [Related]
34. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
[TBL] [Abstract][Full Text] [Related]
35. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.
Krambeck K; Silva V; Silva R; Fernandes C; Cagide F; Borges F; Santos D; Otero-Espinar F; Lobo JMS; Amaral MH
Int J Pharm; 2021 May; 600():120444. PubMed ID: 33713760
[TBL] [Abstract][Full Text] [Related]
36. The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers.
Santos GA; Angelo T; Andrade LM; Silva SMM; Magalhães PO; Cunha-Filho M; Gelfuso GM; Taveira SF; Gratieri T
Colloids Surf B Biointerfaces; 2018 Oct; 170():341-346. PubMed ID: 29940500
[TBL] [Abstract][Full Text] [Related]
37. Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone.
Li B; Ge ZQ
AAPS PharmSciTech; 2012 Mar; 13(1):276-83. PubMed ID: 22234598
[TBL] [Abstract][Full Text] [Related]
38. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.
Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF
Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130
[TBL] [Abstract][Full Text] [Related]
39. Topical delivery of dexamethasone acetate from hydrogel containing nanostructured liquid carriers and the drug.
Tung NT; Huyen VT; Chi SC
Arch Pharm Res; 2015 Nov; 38(11):1999-2007. PubMed ID: 25940221
[TBL] [Abstract][Full Text] [Related]
40. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum.
Guo T; Zhang Y; Zhao J; Zhu C; Feng N
J Nanobiotechnology; 2015 Jul; 13():47. PubMed ID: 26156035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
